SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY

Autor:	Alexander Röth, David J. Kuter, W. Hobbs, T.H.A. Tvedt, Jaime Morales Arias, W. Barcellini, I.C. Weitz, J. Su, Y. Miyakawa, X. Jiang, M.M.O. Barros
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	medicine.medical_specialty Cold agglutinin disease business.industry lcsh:RC633-647.5 Hematology lcsh:Diseases of the blood and blood-forming organs medicine.disease Quality of life (healthcare) Internal medicine medicine Immunology and Allergy In patient business Complement C1s
Zdroj:	Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 57-58 (2020)
ISSN:	2531-1379
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6a398fe8c8030a3f8a21eb838b7df1 http://www.sciencedirect.com/science/article/pii/S2531137920303813 Zobrazit plný text záznamu